MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/02698811251389574

Медицинская библиотека · Journal of psychopharmacology (Oxford, England) · 2025

The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications.

Ricci Valerio, Sarni Alessandro, De Berardis Domenico, Martinotti Giovanni, Maina Giuseppe

СтатьяСистематический обзорПеревод в очереди

Аннотация

This systematic review explores the role of the endocannabinoid system (ECS) in prodromal psychosis and its potential as a therapeutic target. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 22 studies published between 2000 and 2025 were analyzed, comprising preclinical research, genetic studies, neuroimaging investigations, and clinical trials. Converging evidence suggests that ECS alterations precede and potentially contribute to the development of psychotic symptoms, with CB1 receptor modifications and endocannabinoid levels correlating with symptom severity and transition risk to full-blown psychosis. Neuroimaging studies revealed reduced CB1 receptor availability in key brain regions in high-risk subjects, and intervention studies, particularly with cannabidiol-though its therapeutic mechanisms likely extend beyond ECS modulation to include dopaminergic and other neurotransmitter pathways-have shown promising results. Proposed mechanisms of action include stress response attenuation, neuroinflammatory modulation, neurodevelopmental stabilization, and normalization of the dopamine-glutamate interface. Despite limitations of existing studies, primarily small size and short duration, this review provides a solid foundation for developing ECS-targeted interventions as a promising approach to modify disease trajectory during the prodromal phase, potentially offering safer and more effective therapeutic options for individuals at clinical high risk for psychosis.

Для цитирования: Ricci Valerio, Sarni Alessandro, De Berardis Domenico, Martinotti Giovanni, Maina Giuseppe. The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications.. Journal of psychopharmacology (Oxford, England). 2025. DOI: 10.1177/02698811251389574.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.